OutSense has developed a novel technology capable of accurately analyzing and diagnosing human waste from within a standard toilet bowl. Its solution offers a superior monitoring platform that safeguards health and enables early detection of medical conditions. The company’s unique database on human extracts can provide invaluable insight into human physiology.
A medical status report for each person is generated daily in the form of our biological excretions. OutSense is using innovative imaging technologies to reveal this information. The sensor will monitor essential health and wellness parameters and communicate them with a mobile device app. The primary goal is to prevent colorectal cancer by identifying hidden blood in the stool. Hidden blood is a well-established screening tool for colorectal cancer (CRC), currently performed by sending a stool sample to a specialized lab.
Total Funding: $1,400,000
Funding Stage: Series B
Business Stage: Scaling Up
Market: B2B
Company Size: 26 to 50
Founded: 2016
